CWAN insider files Form 144 for 29,700-share NYSE sale

Rhea-AI Filing Summary

A holder of CWAN common stock has filed a Form 144 indicating an intent to sell 29,700 common shares through Morgan Stanley Smith Barney LLC on the NYSE. These shares have an aggregate market value of $644,490.00, compared with 288,154,032 common shares outstanding for the issuer. The shares to be sold were acquired on 11/25/2025 by exercising stock options for cash, with payment made the same day.

The filing also lists prior sales over the past three months for the same account under a Rule 10b5-1 trading plan. These include, for example, 11,275 common shares sold on 11/17/2025 for gross proceeds of $222,611.88 and 11,275 common shares sold on 10/15/2025 for gross proceeds of $202,677.50, along with additional sales in September 2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	29700	644490.00	288154032	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2025	Exercise of Stock Options	Issuer			29700	11/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	11/17/2025	11275	222611.88
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	10/15/2025	11275	202677.50
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	09/30/2025	5919	104631.35
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	09/15/2025	11275	219937.25

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CWAN Form 144 filing disclose?

The Form 144 discloses that a holder of CWAN common stock intends to sell 29,700 common shares on the NYSE under Rule 144.

How many CWAN shares are planned to be sold and what is their value?

The filing states that 29,700 common shares are to be sold, with an aggregate market value of $644,490.00.

How and when were the CWAN shares to be sold acquired?

The 29,700 CWAN shares were acquired on 11/25/2025 through the exercise of stock options, paid for in cash on the same date.

What is the total number of CWAN shares outstanding mentioned in the filing?

The filing reports that the issuer has 288,154,032 common shares outstanding.

Which broker and exchange are involved in the planned CWAN share sale?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with the shares to be sold on the NYSE.

What recent CWAN share sales under a 10b5-1 plan are disclosed?

Recent disclosed sales include 11,275 common shares sold on 11/17/2025 for $222,611.88 and 11,275 common shares sold on 10/15/2025 for $202,677.50, among other September 2025 transactions.

What representation does the seller make about CWAN inside information?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.